KdT is the standard for early-stage frontier science investing; focuses on writing first institutional checks of $500k–$5M by re-architecting the physical world at a molecular level by treating chemistry and biology as the 'software' of the physical world
| Firm name | KdT Ventures |
| Investment thesis/focus | KdT is the standard for early-stage frontier science investing; focuses on writing first institutional checks of $500k–$5M by re-architecting the physical world at a molecular level by treating chemistry and biology as the 'software' of the physical world |
| Location | Austin, Texas |
| Founding year | 2017 |
| Number of partners/investors | 8 total team members |
| Investment stages and check sizes | Pre-seed and Seed stages; check sizes $500K - $3M; $100M+ fund |
| Managing partners | Cain McClary, MD (Founder and Managing Partner) and Mack Healy (Managing Partner) |
| State registration/corporate entity | Not found in public records; appears to operate as KdT Ventures without separate state filing |
| Public email address | mack@kdtvc.com |